<?xml version="1.0" encoding="UTF-8"?>

<document id="DDI-MedLine.d99"> 
   <sentence id="DDI-MedLine.d99.s0" text="Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide.
" new_text="Fluvoxamine@@inhibits@@the@@CYP2C9@@catalyzed@@biotransformation@@of@@tolbutamide@@.@@"> 
      <entity id="DDI-MedLine.d99.s0.e0" charOffset="0-10" type="drug" text="Fluvoxamine" position="0"/>  
      <entity id="DDI-MedLine.d99.s0.e1" charOffset="63-73" type="drug" text="tolbutamide" position="7"/>  
      <pair id="DDI-MedLine.d99.s0.p0" e1="DDI-MedLine.d99.s0.e0" e2="DDI-MedLine.d99.s0.e1" ddi="true" type="mechanism" flags="True" e1_name="Fluvoxamine" e2_name="tolbutamide" e1_pos="0" e2_pos="7" path="0@@1@@5@@7@@">Fluvoxamine@@@@nsubj@@inhibits@@dobj@@biotransformation@@prep_of@@tolbutamide</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d99.s1" text="OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. " new_text="OBJECTIVE@@:@@Our@@objective@@was@@to@@examine@@the@@interaction@@between@@fluvoxamine@@and@@tolbutamide@@to@@confirm@@that@@fluvoxamine@@inhibits@@CYP2C9@@.@@"> 
      <entity id="DDI-MedLine.d99.s1.e0" charOffset="64-74" type="drug" text="fluvoxamine" position="10"/>  
      <entity id="DDI-MedLine.d99.s1.e1" charOffset="80-90" type="drug" text="tolbutamide" position="12"/>  
      <entity id="DDI-MedLine.d99.s1.e2" charOffset="108-118" type="drug" text="fluvoxamine" position="16"/>  
      <pair id="DDI-MedLine.d99.s1.p0" e1="DDI-MedLine.d99.s1.e0" e2="DDI-MedLine.d99.s1.e1" ddi="false" flags="True" e1_name="fluvoxamine" e2_name="tolbutamide" e1_pos="10" e2_pos="12" path="10@@8@@6@@12@@">fluvoxamine@@@@prep_between@@interaction@@dobj@@examine@@conj_and@@tolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s1.p1" e1="DDI-MedLine.d99.s1.e0" e2="DDI-MedLine.d99.s1.e2" ddi="false" flags="True" e1_name="fluvoxamine" e2_name="fluvoxamine" e1_pos="10" e2_pos="16" path="10@@8@@6@@12@@14@@17@@16@@">fluvoxamine@@@@prep_between@@interaction@@dobj@@examine@@conj_and@@tolbutamide@@xcomp@@confirm@@ccomp@@inhibits@@nsubj@@fluvoxamine</pair>  
      <pair id="DDI-MedLine.d99.s1.p2" e1="DDI-MedLine.d99.s1.e1" e2="DDI-MedLine.d99.s1.e2" ddi="false" flags="True" e1_name="tolbutamide" e2_name="fluvoxamine" e1_pos="12" e2_pos="16" path="12@@14@@17@@16@@">tolbutamide@@@@xcomp@@confirm@@ccomp@@inhibits@@nsubj@@fluvoxamine</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d99.s2" text="METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy participants. " new_text="METHODS@@:@@The@@study@@was@@carried@@out@@as@@an@@open@@,@@randomized@@,@@crossover@@design@@with@@14@@healthy@@participants@@.@@"/>  
   <sentence id="DDI-MedLine.d99.s3" text="In period A, all volunteers took 500 mg of tolbutamide orally. " new_text="In@@period@@A@@,@@all@@volunteers@@took@@500@@mg@@of@@tolbutamide@@orally@@.@@"> 
      <entity id="DDI-MedLine.d99.s3.e0" charOffset="43-53" type="drug" text="tolbutamide" position="10"/> 
   </sentence>  
   <sentence id="DDI-MedLine.d99.s4" text="In period B, the volunteers were randomly assigned to one of two groups. " new_text="In@@period@@B@@,@@the@@volunteers@@were@@randomly@@assigned@@to@@one@@of@@two@@groups@@.@@"/>  
   <sentence id="DDI-MedLine.d99.s5" text="Each group took either 150 mg or 75 mg of fluvoxamine a day for 5 days (day -3 to day 2). " new_text="Each@@group@@took@@either@@150@@mg@@or@@75@@mg@@of@@fluvoxamine@@a@@day@@for@@5@@days@@(day@@-3@@to@@day@@2)@@.@@"> 
      <entity id="DDI-MedLine.d99.s5.e0" charOffset="42-52" type="drug" text="fluvoxamine" position="10"/> 
   </sentence>  
   <sentence id="DDI-MedLine.d99.s6" text="The groups then took 500 mg of tolbutamide as a single dose (day 0). " new_text="The@@groups@@then@@took@@500@@mg@@of@@tolbutamide@@as@@a@@single@@dose@@(day@@0)@@.@@"> 
      <entity id="DDI-MedLine.d99.s6.e0" charOffset="31-41" type="drug" text="tolbutamide" position="7"/> 
   </sentence>  
   <sentence id="DDI-MedLine.d99.s7" text="In both periods, blood and urine were sampled at regular intervals. " new_text="In@@both@@periods@@,@@blood@@and@@urine@@were@@sampled@@at@@regular@@intervals@@.@@"/>  
   <sentence id="DDI-MedLine.d99.s8" text="Plasma was analyzed for tolbutamide, and urine was analyzed for tolbutamide and its two metabolites, 4-hydroxytolbutamide and carboxytolbutamide by means of HPLC. " new_text="Plasma@@was@@analyzed@@for@@tolbutamide@@,@@and@@urine@@was@@analyzed@@for@@tolbutamide@@and@@its@@two@@metabolites@@,@@4-hydroxytolbutamide@@and@@carboxytolbutamide@@by@@means@@of@@HPLC@@.@@"> 
      <entity id="DDI-MedLine.d99.s8.e0" charOffset="24-34" type="drug" text="tolbutamide" position="4"/>  
      <entity id="DDI-MedLine.d99.s8.e1" charOffset="64-74" type="drug" text="tolbutamide" position="11"/>  
      <entity id="DDI-MedLine.d99.s8.e2" charOffset="101-120" type="drug_n" text="4-hydroxytolbutamide" position="17"/>  
      <entity id="DDI-MedLine.d99.s8.e3" charOffset="126-143" type="drug_n" text="carboxytolbutamide" position="19"/>  
      <pair id="DDI-MedLine.d99.s8.p0" e1="DDI-MedLine.d99.s8.e0" e2="DDI-MedLine.d99.s8.e1" ddi="false" flags="True" e1_name="tolbutamide" e2_name="tolbutamide" e1_pos="4" e2_pos="11" path="4@@2@@9@@11@@">tolbutamide@@@@prep_for@@analyzed@@conj_and@@analyzed@@prep_for@@tolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s8.p1" e1="DDI-MedLine.d99.s8.e0" e2="DDI-MedLine.d99.s8.e2" ddi="false" flags="True" e1_name="tolbutamide" e2_name="4-hydroxytolbutamide" e1_pos="4" e2_pos="17" path="4@@2@@9@@11@@17@@">tolbutamide@@@@prep_for@@analyzed@@conj_and@@analyzed@@prep_for@@tolbutamide@@amod@@4-hydroxytolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s8.p2" e1="DDI-MedLine.d99.s8.e0" e2="DDI-MedLine.d99.s8.e3" ddi="false" flags="True" e1_name="tolbutamide" e2_name="carboxytolbutamide" e1_pos="4" e2_pos="19" path="4@@2@@9@@11@@19@@">tolbutamide@@@@prep_for@@analyzed@@conj_and@@analyzed@@prep_for@@tolbutamide@@amod@@carboxytolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s8.p3" e1="DDI-MedLine.d99.s8.e1" e2="DDI-MedLine.d99.s8.e2" ddi="false" flags="True" e1_name="tolbutamide" e2_name="4-hydroxytolbutamide" e1_pos="11" e2_pos="17" path="11@@17@@">tolbutamide@@@@amod@@4-hydroxytolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s8.p4" e1="DDI-MedLine.d99.s8.e1" e2="DDI-MedLine.d99.s8.e3" ddi="false" flags="True" e1_name="tolbutamide" e2_name="carboxytolbutamide" e1_pos="11" e2_pos="19" path="11@@19@@">tolbutamide@@@@amod@@carboxytolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s8.p5" e1="DDI-MedLine.d99.s8.e2" e2="DDI-MedLine.d99.s8.e3" ddi="false" flags="True" e1_name="4-hydroxytolbutamide" e2_name="carboxytolbutamide" e1_pos="17" e2_pos="19" path="17@@19@@">4-hydroxytolbutamide@@@@conj_and@@carboxytolbutamide</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d99.s9" text="RESULTS: During treatment with fluvoxamine, there was a statistically significant decrease in the median of the total clearance of tolbutamide, from 845 mL/h to 688 mL/h, among the volunteers who received 75 mg/d. " new_text="RESULTS@@:@@During@@treatment@@with@@fluvoxamine@@,@@there@@was@@a@@statistically@@significant@@decrease@@in@@the@@median@@of@@the@@total@@clearance@@of@@tolbutamide@@,@@from@@845@@mL/h@@to@@688@@mL/h@@,@@among@@the@@volunteers@@who@@received@@75@@mg/d@@.@@"> 
      <entity id="DDI-MedLine.d99.s9.e0" charOffset="31-41" type="drug" text="fluvoxamine" position="5"/>  
      <entity id="DDI-MedLine.d99.s9.e1" charOffset="131-141" type="drug" text="tolbutamide" position="21"/>  
      <pair id="DDI-MedLine.d99.s9.p0" e1="DDI-MedLine.d99.s9.e0" e2="DDI-MedLine.d99.s9.e1" ddi="true" type="mechanism" flags="True" e1_name="fluvoxamine" e2_name="tolbutamide" e1_pos="5" e2_pos="21" path="5@@3@@8@@12@@15@@19@@21@@">fluvoxamine@@@@prep_with@@treatment@@prep_during@@was@@nsubj@@decrease@@prep_in@@median@@prep_of@@clearance@@prep_of@@tolbutamide</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d99.s10" text="There was a reduction that reached borderline statistical significance in the group that received 150 mg/d of tolbutamide. " new_text="There@@was@@a@@reduction@@that@@reached@@borderline@@statistical@@significance@@in@@the@@group@@that@@received@@150@@mg/d@@of@@tolbutamide@@.@@"> 
      <entity id="DDI-MedLine.d99.s10.e0" charOffset="110-120" type="drug" text="tolbutamide" position="17"/> 
   </sentence>  
   <sentence id="DDI-MedLine.d99.s11" text="The clearance by means of 4-hydroxytolbutamide and carboxytolbutamide was significantly reduced in both groups (ie, from 901 mL/h to 318 mL/h in the group that received 150 mg of tolbutamide per day and from 723 mL/h to 457 mL/h in the group that received 75 mg of tolbutamide per day). " new_text="The@@clearance@@by@@means@@of@@4-hydroxytolbutamide@@and@@carboxytolbutamide@@was@@significantly@@reduced@@in@@both@@groups@@(ie@@,@@from@@901@@mL/h@@to@@318@@mL/h@@in@@the@@group@@that@@received@@150@@mg@@of@@tolbutamide@@per@@day@@and@@from@@723@@mL/h@@to@@457@@mL/h@@in@@the@@group@@that@@received@@75@@mg@@of@@tolbutamide@@per@@day)@@.@@"> 
      <entity id="DDI-MedLine.d99.s11.e0" charOffset="26-45" type="drug_n" text="4-hydroxytolbutamide" position="5"/>  
      <entity id="DDI-MedLine.d99.s11.e1" charOffset="51-68" type="drug_n" text="carboxytolbutamide" position="7"/>  
      <entity id="DDI-MedLine.d99.s11.e2" charOffset="179-189" type="drug" text="tolbutamide" position="30"/>  
      <entity id="DDI-MedLine.d99.s11.e3" charOffset="265-275" type="drug" text="tolbutamide" position="48"/>  
      <pair id="DDI-MedLine.d99.s11.p0" e1="DDI-MedLine.d99.s11.e0" e2="DDI-MedLine.d99.s11.e1" ddi="false" flags="True" e1_name="4-hydroxytolbutamide" e2_name="carboxytolbutamide" e1_pos="5" e2_pos="7" path="5@@7@@">4-hydroxytolbutamide@@@@conj_and@@carboxytolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s11.p1" e1="DDI-MedLine.d99.s11.e0" e2="DDI-MedLine.d99.s11.e2" ddi="false" flags="True" e1_name="4-hydroxytolbutamide" e2_name="tolbutamide" e1_pos="5" e2_pos="30" path="5@@1@@10@@18@@21@@24@@26@@28@@30@@">4-hydroxytolbutamide@@@@prep_by_means_of@@clearance@@nsubjpass@@reduced@@prep_from@@mL/h@@prep_to@@mL/h@@prep_in@@group@@rcmod@@received@@dobj@@mg@@prep_of@@tolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s11.p2" e1="DDI-MedLine.d99.s11.e0" e2="DDI-MedLine.d99.s11.e3" ddi="false" flags="True" e1_name="4-hydroxytolbutamide" e2_name="tolbutamide" e1_pos="5" e2_pos="48" path="5@@1@@10@@18@@36@@39@@42@@44@@46@@48@@">4-hydroxytolbutamide@@@@prep_by_means_of@@clearance@@nsubjpass@@reduced@@prep_from@@mL/h@@prep_from@@mL/h@@prep_to@@mL/h@@prep_in@@group@@rcmod@@received@@dobj@@mg@@prep_of@@tolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s11.p3" e1="DDI-MedLine.d99.s11.e1" e2="DDI-MedLine.d99.s11.e2" ddi="false" flags="True" e1_name="carboxytolbutamide" e2_name="tolbutamide" e1_pos="7" e2_pos="30" path="7@@1@@10@@18@@21@@24@@26@@28@@30@@">carboxytolbutamide@@@@prep_by_means_of@@clearance@@nsubjpass@@reduced@@prep_from@@mL/h@@prep_to@@mL/h@@prep_in@@group@@rcmod@@received@@dobj@@mg@@prep_of@@tolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s11.p4" e1="DDI-MedLine.d99.s11.e1" e2="DDI-MedLine.d99.s11.e3" ddi="false" flags="True" e1_name="carboxytolbutamide" e2_name="tolbutamide" e1_pos="7" e2_pos="48" path="7@@1@@10@@18@@36@@39@@42@@44@@46@@48@@">carboxytolbutamide@@@@prep_by_means_of@@clearance@@nsubjpass@@reduced@@prep_from@@mL/h@@prep_from@@mL/h@@prep_to@@mL/h@@prep_in@@group@@rcmod@@received@@dobj@@mg@@prep_of@@tolbutamide</pair>  
      <pair id="DDI-MedLine.d99.s11.p5" e1="DDI-MedLine.d99.s11.e2" e2="DDI-MedLine.d99.s11.e3" ddi="false" flags="True" e1_name="tolbutamide" e2_name="tolbutamide" e1_pos="30" e2_pos="48" path="30@@28@@26@@24@@21@@18@@36@@39@@42@@44@@46@@48@@">tolbutamide@@@@prep_of@@mg@@dobj@@received@@rcmod@@group@@prep_in@@mL/h@@prep_to@@mL/h@@prep_from@@mL/h@@prep_to@@mL/h@@prep_in@@group@@rcmod@@received@@dobj@@mg@@prep_of@@tolbutamide</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d99.s12" text="Thus there was a tendency toward a more pronounced inhibition of the 4-hydroxylation during treatment with 150 mg/d of fluvoxamine compared with 75 mg/d, but the difference was not statistically significant. " new_text="Thus@@there@@was@@a@@tendency@@toward@@a@@more@@pronounced@@inhibition@@of@@the@@4-hydroxylation@@during@@treatment@@with@@150@@mg/d@@of@@fluvoxamine@@compared@@with@@75@@mg/d@@,@@but@@the@@difference@@was@@not@@statistically@@significant@@.@@"> 
      <entity id="DDI-MedLine.d99.s12.e0" charOffset="119-129" type="drug" text="fluvoxamine" position="19"/> 
   </sentence>  
   <sentence id="DDI-MedLine.d99.s13" text="CONCLUSION: Fluvoxamine is a moderate inhibitor of CYP2C9 in vivo." new_text="CONCLUSION@@:@@Fluvoxamine@@is@@a@@moderate@@inhibitor@@of@@CYP2C9@@in@@vivo@@.@@"> 
      <entity id="DDI-MedLine.d99.s13.e0" charOffset="12-22" type="drug" text="Fluvoxamine" position="2"/> 
   </sentence> 
</document>
